Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Treatment Works with Award-Winning Brand Agency to Develop Cara Branding


VANCOUVER, British Columbia, Oct. 21, 2021 (GLOBE NEWSWIRE) -- International Inc. (“Treatment or the (“Company”) (CSE: TRUE) is a healthcare technology company with a passion for supporting consumers with easy, supportive solutions. The Company’s unique, proprietary Global Library of Medicine and AI engine will be leveraged in their first product, an AI health assistant called Cara, available to consumers through a mobile app.

Eight months of consumer testing revealed that one of the biggest challenges of healthcare adoption is creating a supportive and caring experience for consumers. With the development of the Cara brand, Treatment has designed an approachable and friendly AI character. Cara will help consumers throughout their healthcare journey, across all future components of the vast platform technology. Treatment enlisted the help of award-winning branding agency, Rethink, to design the Cara brand direction to disrupt traditional healthcare experiences and create a fun experience for the consumer.

“Before we could build the Cara character, we needed to define Treatment’s driving philosophy: that health management should extend beyond the doctor’s office. Cara is that driving philosophy brought to life: knowledgeable, reassuring, trustworthy, and there for you every step of the way. Our job as the creative agency partner was to develop Cara’s personality and visuals — it’s been an exciting challenge for our team,” says Darren Yada, Managing Partner, Strategy at Rethink.

Treatment’s much anticipated first product, Cara, is a virtual assistant that will leverage Treatment’s GLM and AI engine, and will be made available to consumers through a mobile app.

About is a disruptive healthcare technology company that is harnessing the power of AI to help global citizens improve their health through personalized recommendations and insights. Based in Vancouver with a US subsidiary, the company spent the last five years working with a team of world-class doctors, engineers, mathematicians, and AI specialists to develop a complex AI engine that leverages the most robust, personalized data to generate highly predictive and accurate insights. is the parent company of Treatment Mobile, and Cara, an intelligent digital health assistant which will empower people to take control of their health through an innovative mobile app, powered by Treatment’s exclusive AI engine.

For more investor information on please visit

Forward Looking Statement

This news release contains forward-looking statements relating to the future operations of, International, Inc. (Treatment) and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Treatment, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment's expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

For more information:

Investor Contact:

Primary Logo